Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy

Heart

Volumn 93, Issue 9, 2007, Pages 1044-1045

  Woo, Anna ^a,b   Monakier, Daniel ^b   Harris, Louise ^b   Hill, Ann ^b   Shah, Prasad ^b   Wigle, E Douglas ^b   Rakowski, Harry ^b   Rozenblyum, Evelyn ^b   Cameron, Douglas A ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART ARREST; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESUSCITATION; SCHOOL CHILD; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 34548188742     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2006.090290     Document Type: Article

References (5)

1. Maron BJ, McKenna WJ, Danielson GK, et al. Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42:1687-713.
2. Maron BJ, Shen WK, Link MS, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000;342:365-73.
3. Begley DA, Mohiddin SA, Tripodi D, et al. Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 2003;26:1887-96.
4. Korte T, Koditz H, Niehaus M, et al. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004;27:924-32.
5. Nanthakumor K, Dorian P, Paquette M, et al. Is inappropriate implantable defibrillator shock therapy predictable? J Interv Card Electrophysiol 2003;8:215-20.